• Nektar, Pfizer Announce Oncology Clinical Collaboration americanpharmaceuticalreview
    November 10, 2018
    Nektar Therapeutics has entered into an oncology clinical collaboration with Pfizer to evaluate several combination regimens in multiple cancer settings, including metastatic castration-resistant prostate cancer (mCRPC) and squamous cell carcinoma of the
PharmaSources Customer Service